Anti-Mouse CD289 (TLR9) FITC
description
Additional Information
Clone:
|
M9.D6
|
Format:
|
FITC
|
Applications:
|
FC
|
Reactivity:
|
Mouse
|
Isotype:
|
Rat IgG2a
|
Research Interest: | Innate Immunity |
---|---|
Cell Type: | Macrophage / Monocyte, Dendritic Cells |
Application: | FC |
Clone: | M9.D6 |
Preparation:
|
The product should be stored undiluted at 4°C and should be protected from prolonged exposure to light. Do not freeze. The monoclonal antibody was purified utilizing affinity chromatography and unreacted dye was removed from the product.
|
Formulation:
|
Phosphate-buffered aqueous solution, ≤0.09% Sodium azide, may contain carrier protein/stabilizer, ph7.2.
|
References:
|
Kubo, T., Uchida, Y., Watanabe, Y., Abe, M., Nakamura, A., Ono, M., ... & Takai, T. (2009). Augmented TLR9-induced Btk activation in PIR-B–deficient B-1 cells provokes excessive autoantibody production and autoimmunity. The Journal of experimental medicine, 206(9), 1971-1982. Fukata, M., Breglio, K., Chen, A., Vamadevan, A. S., Goo, T., Hsu, D., ... & Abreu, M. T. (2008). The myeloid differentiation factor 88 (MyD88) is required for CD4+ T cell effector function in a murine model of inflammatory bowel disease.The Journal of Immunology, 180(3), 1886-1894. Miranda-Hernandez, S., Gerlach, N., Fletcher, J. M., Biros, E., Mack, M., Körner, H., & Baxter, A. G. (2011). Role for MyD88, TLR2 and TLR9 but not TLR1, TLR4 or TLR6 in experimental autoimmune encephalomyelitis. The Journal of Immunology, 187(2), 791-804. |